John D Ratliff Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for John D Ratliff.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of John D Ratliff. John D Ratliff is a CEO, Covance Drug Development in LABORATORY CORP OF AMERICA HOLDINGS ($LH) and a President and COO in Quintiles Transnational Holdings Inc. ($Q).
Address: C/O QUINTILES TRANSNATIONAL HOLDINGS INC 4820 EMPEROR BLVD. DURHAM 27703 NC
Companies in which John D Ratliff is an Insider
IQVIA HOLDINGS INC.
Industry: SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731]
Position of John D Ratliff: President and COO
Holdings: 0 shares
Current Value: $0
Latest Transaction: Nov 19 2013
$IQV Market Capitalization: $19.23B
$IQV Previous Close: $77.99
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
LABORATORY CORP OF AMERICA HOLDINGS
Industry: SERVICES-MEDICAL LABORATORIES [8071]
Position of John D Ratliff: CEO, Covance Drug Development
Holdings: 18,025 shares
Current Value: $2,340,727
Latest Transaction: Apr 05 2019
$LH Market Capitalization: $13.45B
$LH Previous Close: $129.86
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of John D Ratliff
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Apr 05 2019 | LH | LABORATORY CORP OF ... | Ratliff John D | CEO, Covance Drug D ... | Option Exercise | M | 0.00 | 2,424 | 0 | 19,787 | |
| Apr 05 2019 | LH | LABORATORY CORP OF ... | Ratliff John D | CEO, Covance Drug D ... | Payment of Exercise | F | 156.68 | 1,084 | 169,841 | 16,941 | 18 K to 16.9 K (-6.01 %) |
| Apr 05 2019 | LH | LABORATORY CORP OF ... | Ratliff John D | CEO, Covance Drug D ... | Buy | M | 0.00 | 2,424 | 0 | 18,025 | 15.6 K to 18 K (+15.54 %) |
| Feb 13 2019 | LH | LABORATORY CORP OF ... | Ratliff John D | CEO, Covance Drug D ... | Option Exercise | M | 0.00 | 6,100 | 0 | 18,374 | |
| Feb 13 2019 | LH | LABORATORY CORP OF ... | Ratliff John D | CEO, Covance Drug D ... | Payment of Exercise | F | 144.29 | 1,973 | 284,684 | 14,792 | 16.8 K to 14.8 K (-11.77 %) |
| Feb 13 2019 | LH | LABORATORY CORP OF ... | Ratliff John D | CEO, Covance Drug D ... | Buy | M | 0.00 | 6,100 | 0 | 16,765 | 10.7 K to 16.8 K (+57.20 %) |
| Feb 11 2019 | LH | LABORATORY CORP OF ... | Ratliff John D | CEO, Covance Drug D ... | Option Exercise | M | 0.00 | 1,863 | 0 | 24,474 |